15 May 2013 - Mesoblast's Preclinical Trial Results of Intracoronary Cell Therapy Published in Circulation Research
22 April 2013 – Mesoblast Reports Positive Interim Results in Phase 2 Trial of Proprietary Adultn Stem Cell for Intervertebral Disc Repair
17 April 2013 – Mesoblast Appoints Renowned Cardiovascular Surgeon Dr Eric A. Rose to Board of Directors
12 April 2013 - Mesoblast Chief Executive Honoured at the Vatican with Inaugural Pontifical Award for Innovation
13 March 2013 - Mesoblast Completes A$170m Private Placement
The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...
Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...
Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...
